ECRIN newsletter - April 2020 issue
View this email in your browser
As the world is confronted with the COVID-19 crisis, all working in healthcare systems taking care of patients have the highest priority. The COVID-19 crises requires researchers to join forces worldwide to find a cure and a vaccine, and sharing research data is a critical step in this global cooperation effort. In this special edition of our newsletter we would like to inform you about our relevant services to help fight the COVID-19 pandemic. In this context, ECRIN has established a COVID-19 Taskforce with its national partners:
  • Review and digest the scientific literature on COVID clinical trials
  • Develop a metadata repository for COVID trials making all the non-sensitive COVID-19 trial data accessible
  • Develop a database on the regulatory, ethical and data protection fast track approvals across all European countries
  • Ensure preparedness of its national clinical trial unit (CTU) partners for COVID trials
  • Combine and coordinate national initiatives to promote multinational rather than national trials, including through connection with national funders, sponsors investigators and CTUs
  • Develop partnership with national and pan-European investigation networks on infectious diseases and intensive care
  • Outreach to investigators, sponsors, patients, policymakers, funders, and citizens
  • International cooperation and outreach, including with WHO and through CRIGH and other initiatives
Clinical Trails play a crucial role in the development of vaccines and cures, especially for COVID-19. ECRIN has launched the Clinical Research Metadata Repository, including COVID-19 data, allowing the discovery of clinical studies and related data objects, as for example protocol, information sheet and consent form, data management plan, statistical analysis plan, case report form, results, publications, descriptive metadata, etc..

COVID-19 Meta Data RepositoryThe Clinical Research Metadata Repository is available for all scientific researchers, especially for those working on COVID-19. The Clinical Research Metadata Repository is updated regularly through collection of data from the most important sources of information worldwide, from New Zealand to The Netherlands and from Japan to Lebanon.

How it works
The Clinical Research Metadata Repository allows scientific users to search freely and without registration for documents and data linked to a clinical research study, and to obtain information on the accessibility of those results. Where results are publicly available, e.g. a link to an open access journal article or a trial registry entry, a direct link to the source is provided. Where results are available under restricted access, then as far as possible the details of the access arrangements are displayed within the portal, provided with a URL to a description of the access procedure.

ECRIN shares a curated list of the most relevant articles presenting results from COVID19 trials on a weekly basis, including pre-prints. This list is non-exhaustive, and focuses on pharmaceutical and non-pharmaceutical interventions for COVID19 treatment and prevention, and on interventions for the mitigation of the epidemic.

It can be downloaded in a PDF format here. Weekly updates are highlighted in a different color.

On the website we published a list of calls for funding for COVID19, curated by ECRIN and updated on a weekly basis. The calls featured in this list focus on research opportunities for European investigators, mainly in the field of clinical research, or areas underpinning clinical research. The list is organised per country, and shows the funding body, type of study, the amount available, the deadline for participation, and if available contains link to the specific webpage.
Over 500 clinical trials of potential COVID-19 treatments and interventions have been launched worldwide. We have published a summary of the main international registries and European national registries to search for planned or on-going COVID-19 clinical trials.
On the ECRIN website we published a special page containing information about the regulatory and ethical consideration for ongoing clinical trials during the COVID19 outbreak and fast track procedures for COVID-19 clinical trials. Per country and agency we provide you with the matching document or link to the national document.

The European Research Infrastructures responded promptly to the development of the corona crisis. Many Research Infrastructures joined forces and launched services to support all scientific response to the COVID-19 virus, and those working to find a cure and a vaccine for it.The European Strategy Forum on Research Infrastructures (ESFRI) and the Lifesciences-RI project, publicised an overview of available dedicated COVID-19 services. Please click on the logo to go the overview:

ESFRILifescience RI

More News from ECRIN's scientific partners:
Due to the current situation with the coronavirus, the International Clinical Trials Day 2020 in Berlin have been cancelled. The next International Clinical Trials Day will be held on May 27th 2021, also in Berlin. The topic of ICTD 2021 will be (patient-)recruitment in clinical trials, and more details to come as soon as possible!

Follow ECRIN on Twitter to stay up to date, and please reschedule your agenda to:

Date: 27 May 2021
Location: Langenbeck-Virchow-Haus, Berlin, Germany

We count on you to meet each other in Berlin, 27 May 2021. See you then!
Follow ECRIN on Twitter
Follow ECRIN on LinkedIn
Visit the ECRIN website

By subscribing to our newsletter, you have provided us with your name and email address. This personal data will be used solely for the purpose of keeping you up-to-date with ECRIN activities. We will keep your data for as long as your newsletter subscription is active. (Note: you may choose to unsubscribe at any time by clicking on the 'unsubscribe' link located at the bottom of our newsletter.)

To send you the newsletter, we use a very popular provider called MailChimp. If you subscribe to our newsletter, you consent that we send your contact information to Mailchimp, which stores your contact information in their servers.

Please be aware that Mailchimp has developed its own policy with respect to the GDPR and its own contractual terms and conditions. Please read their policy and if you do not agree with their policy, you must unsubscribe immediately from our newsletter. Should you have any questions concerning the way in which ECRIN is processing your data, please refer them to the following address:
Copyright © 2020 ECRIN, All rights reserved.

Our mailing address is:
5 rue Watt
Paris 75013

Add us to your address book

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list

Email Marketing Powered by Mailchimp